CME Group and BM&FBOVESPA announced on February 12, 2010, that they have agreed to become Global Preferred Strategic Partners and will develop a new multi-asset class electronic trading platform that will be deployed by BM&FBOVESPA for use in its cash equities and derivatives markets.
As part of the expanded partnership, BM&FBOVESPA will increase its ownership interest in CME Group to 5%, the same approximate stake CME Group currently has in BM&FBOVESPA. The new multi-asset class electronic trading platform will be jointly developed by both exchanges and will be used by BM&FBOVESPA in its cash equities and derivatives markets, and both exchanges will have the ability to license the platform to other exchanges internationally. The new platform will offer customers an industry leading technology platform for global derivatives and equities trading, with the additional benefit of having access to an integrated derivatives and equities technology solution.
Click here to read the full version of the Material Fact